Terug
Dagbereik
€ 67,00
€ 71,57
52-Weeksbereik
€ 66,50
€ 112,30
Volume
200
50D / 200D Gem.
€ 82,13
/
€ 89,63
Vorige Slotkoers
€ 67,00
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 19,2 | 0,3 |
| P/B | 2,0 | 3,0 |
| ROE % | 11,3 | 3,7 |
| Net Margin % | 15,9 | 3,8 |
| Rev Growth 5Y % | 7,7 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 7,02
€ 6,76 – € 7,32
|
1,54B | 1 |
| FY2028 |
€ 5,95
€ 5,73 – € 6,20
|
1,41B | 1 |
| FY2027 |
€ 5,33
€ 5,13 – € 5,55
|
1,32B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-07-31 | N/A | € 1,03 | — |
| 2025-03-13 | € 2,21 | € 1,06 | -52,0% |
| 2024-12-31 | N/A | € 0,91 | — |
| 2024-11-05 | N/A | € 0,93 | — |
| 2024-07-29 | N/A | € 1,01 | — |
| 2024-05-10 | N/A | € 0,93 | — |
| 2023-12-30 | N/A | € 0,99 | — |
| 2023-09-30 | N/A | € 0,49 | — |
Dividend History
Yield
0,01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 18, 2026 | May 20, 2026 | € 1,51 | 2,25% |
| May 20, 2025 | May 21, 2025 | € 1,35 | 1,34% |
| May 20, 2024 | May 22, 2024 | € 1,25 | 1,24% |
| May 22, 2023 | May 24, 2023 | € 1,19 | 1,07% |
| May 23, 2022 | May 25, 2022 | € 1,12 | 1,07% |
| May 24, 2021 | May 26, 2021 | € 1,22 | 0,66% |
| Jun 15, 2020 | Jun 17, 2020 | € 1,07 | 0,60% |
| May 20, 2019 | May 22, 2019 | € 1,01 | 2,59% |
| Dec 27, 2018 | Dec 31, 2018 | € 2,05 | 3,47% |
| May 21, 2018 | May 23, 2018 | € 1,00 | 1,07% |
| May 22, 2017 | May 24, 2017 | € 0,90 | 1,56% |
| May 23, 2016 | May 25, 2016 | € 0,73 | 1,33% |
| May 18, 2015 | May 20, 2015 | € 0,68 | 1,57% |
| May 19, 2014 | May 22, 2014 | € 0,75 | 1,55% |
| May 20, 2013 | May 23, 2013 | € 0,64 | 4,53% |
| Dec 27, 2012 | Jan 03, 2013 | € 1,10 | 6,35% |
| May 21, 2012 | May 24, 2012 | € 0,59 | 2,21% |
| Jun 20, 2011 | Jun 23, 2011 | € 0,57 | 1,02% |
| Jun 21, 2010 | Jun 24, 2010 | € 0,25 | 0,66% |
| Jun 15, 2009 | Jun 18, 2009 | € 0,17 | 0,65% |
Belangrijkste Punten
Revenue grew 7,69% annually over 5 years — modest growth
Earnings grew 17,68% over the past year
ROE of 11,27% — decent returns on equity
Net margin of 15,87% shows strong profitability
Generating 239,07M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,45%
Groei
Revenue Growth (5Y)
7,69%
Revenue (1Y)3,24%
Earnings (1Y)17,68%
FCF Growth (3Y)-6,87%
Kwaliteit
Return on Equity
11,27%
ROIC6,88%
Net Margin15,87%
Op. Margin21,79%
Veiligheid
Debt / Equity
0,56
Current Ratio3,39
Interest Coverage9,03
Waardering
P/E Ratio
19,21
Forward P/EN/A
P/B Ratio2,01
EV/EBITDA16,58
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,24% | Revenue Growth (3Y) | -6,68% |
| Earnings Growth (1Y) | 17,68% | Earnings Growth (3Y) | -11,64% |
| Revenue Growth (5Y) | 7,69% | Earnings Growth (5Y) | -6,67% |
| Profitability | |||
| Revenue (TTM) | 1,19B | Net Income (TTM) | 188,11M |
| ROE | 11,27% | ROA | 5,69% |
| Gross Margin | 65,94% | Operating Margin | 21,79% |
| Net Margin | 15,87% | Free Cash Flow (TTM) | 239,07M |
| ROIC | 6,88% | FCF Growth (3Y) | -6,87% |
| Safety | |||
| Debt / Equity | 0,56 | Current Ratio | 3,39 |
| Interest Coverage | 9,03 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 19,21 | Forward P/E | N/A |
| P/B Ratio | 2,01 | P/S Ratio | 3,05 |
| PEG Ratio | 1,76 | Forward PEG | N/A |
| EV/EBITDA | 16,58 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 6,61% | ||
| Market Cap | 3,61B | Enterprise Value | 4,28B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1,19B | 1,15B | 1,36B | 1,24B | 881,31M |
| Net Income | 188,11M | 159,85M | 240,91M | 310,97M | 247,87M |
| EPS (Diluted) | 3,37 | 2,87 | 4,15 | 5,40 | 4,50 |
| Gross Profit | 781,70M | 741,19M | 900,61M | 824,77M | 602,91M |
| Operating Income | 258,33M | 216,26M | 351,26M | 419,50M | 324,23M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 3,30B | 3,21B | 3,41B | 3,23B | 1,25B |
| Total Liabilities | 1,51B | 1,67B | 1,89B | 1,86B | 290,13M |
| Shareholders' Equity | 1,80B | 1,54B | 1,52B | 1,37B | 954,68M |
| Total Debt | 1,01B | 1,19B | 1,35B | 1,40B | 34,66M |
| Cash & Equivalents | 344,27M | 280,31M | 241,78M | 403,02M | 339,88M |
| Current Assets | 932,53M | 982,69M | 1,07B | 958,29M | 713,92M |
| Current Liabilities | 275,30M | 320,12M | 347,02M | 298,23M | 160,21M |